FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3146097190> ?p ?o ?g. }

• W3146097190 abstract "BACKGROUND: Previous study suggested that Chinese Herbal Medicine (CHM) Formula Huashibaidu granule might shorten disease course of Corona Virus Disease 2019 (COVID-19) patients. Our research aims to investigate the early treatment effect of Huashibaidu granule in mild COVID-19 patients under well clinical management.METHODS: An unblended cluster-randomized clinical trial was conducted at the Dongxihu FangCang hospital. 2 cabins were randomly allocated to CHM or control group, with 204 randomly sampled mild COVID-19 patients in each cabin. All participants received a 7-day conventional treatment, and CHM group cabin used additional Huashibaidu granule 10g twice daily. Participants were followed up until they met clinical endpoint. The primary outcome was patient become worsening before clinical endpoint occurred. The secondary outcomes was discharge with cure before clinical endpoint occurred and relief of composite symptoms after 7 days treatment.FINDINGS: All 408 participants were followed up to meet clinical endpoint and included in statistical analysis. The baseline characteristics were comparable between 2 groups. The number of worsening patients in the CHM group was 5 (2.5%), and that in the control group was 16 (7.8%). There was a significant difference between groups (P=0.014). 8 foreseeable mild adverse events occurred without statistical difference between groups.INTERPRETATION: 7-day early treatment with Huashibaidu granule reduced worsening conversion of mild COVID-19 patients. Our study supports Huashibaidu Granule as an active option for early treatment of mild COVID-19 in similar medical locations with well management.TRIAL REGISTRATION: The Chinese Clinical Trial Registry: ChiCTR2000029763.FUNDING: This study was supported by “National Key R&D Program of China” (No.2020YFC0841500).DECLARATION OF INTERESTS: The authors guaranteed that there existed no competing interest in this paper.ETHICS APPROVAL STATEMENT: Ethics Review Committee of Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Approval of Ethical Review Acceptance Number: S2020-001; Approval Number: P20001/PJ01." @default.
• W3146097190 created "2021-04-13" @default.
• W3146097190 creator A5001858374 @default.
• W3146097190 creator A5002391709 @default.
• W3146097190 creator A5005032895 @default.
• W3146097190 creator A5006569282 @default.
• W3146097190 creator A5007207770 @default.
• W3146097190 creator A5008480409 @default.
• W3146097190 creator A5009887300 @default.
• W3146097190 creator A5016502230 @default.
• W3146097190 creator A5016889825 @default.
• W3146097190 creator A5017424893 @default.
• W3146097190 creator A5018204892 @default.
• W3146097190 creator A5019560977 @default.
• W3146097190 creator A5020298122 @default.
• W3146097190 creator A5020819058 @default.
• W3146097190 creator A5023718426 @default.
• W3146097190 creator A5025578020 @default.
• W3146097190 creator A5025684845 @default.
• W3146097190 creator A5026140364 @default.
• W3146097190 creator A5027475930 @default.
• W3146097190 creator A5028627935 @default.
• W3146097190 creator A5030202287 @default.
• W3146097190 creator A5030921116 @default.
• W3146097190 creator A5030955342 @default.
• W3146097190 creator A5031387776 @default.
• W3146097190 creator A5032764121 @default.
• W3146097190 creator A5040040696 @default.
• W3146097190 creator A5040471504 @default.
• W3146097190 creator A5040908309 @default.
• W3146097190 creator A5041129699 @default.
• W3146097190 creator A5043098150 @default.
• W3146097190 creator A5043360958 @default.
• W3146097190 creator A5044842689 @default.
• W3146097190 creator A5045377014 @default.
• W3146097190 creator A5048295434 @default.
• W3146097190 creator A5048352086 @default.
• W3146097190 creator A5048353951 @default.
• W3146097190 creator A5048826252 @default.
• W3146097190 creator A5052002691 @default.
• W3146097190 creator A5053106110 @default.
• W3146097190 creator A5058231860 @default.
• W3146097190 creator A5064235508 @default.
• W3146097190 creator A5064555565 @default.
• W3146097190 creator A5066211456 @default.
• W3146097190 creator A5066716873 @default.
• W3146097190 creator A5069032407 @default.
• W3146097190 creator A5070467313 @default.
• W3146097190 creator A5074461919 @default.
• W3146097190 creator A5076313042 @default.
• W3146097190 creator A5080581580 @default.
• W3146097190 creator A5089460696 @default.
• W3146097190 date "2021-01-01" @default.
• W3146097190 modified "2023-10-14" @default.
• W3146097190 title "Early Treatment Effect of Chinese Herbal Medicine Formula Huashibaidu Granule on Mild COVID-19 Patients in Fangcang Hospital: An Unblinded, Cluster-Randomized Clinical Trial" @default.
• W3146097190 doi "https://doi.org/10.2139/ssrn.3778703" @default.
• W3146097190 hasPublicationYear "2021" @default.
• W3146097190 type Work @default.
• W3146097190 sameAs 3146097190 @default.
• W3146097190 citedByCount "0" @default.
• W3146097190 crossrefType "journal-article" @default.
• W3146097190 hasAuthorship W3146097190A5001858374 @default.
• W3146097190 hasAuthorship W3146097190A5002391709 @default.
• W3146097190 hasAuthorship W3146097190A5005032895 @default.
• W3146097190 hasAuthorship W3146097190A5006569282 @default.
• W3146097190 hasAuthorship W3146097190A5007207770 @default.
• W3146097190 hasAuthorship W3146097190A5008480409 @default.
• W3146097190 hasAuthorship W3146097190A5009887300 @default.
• W3146097190 hasAuthorship W3146097190A5016502230 @default.
• W3146097190 hasAuthorship W3146097190A5016889825 @default.
• W3146097190 hasAuthorship W3146097190A5017424893 @default.
• W3146097190 hasAuthorship W3146097190A5018204892 @default.
• W3146097190 hasAuthorship W3146097190A5019560977 @default.
• W3146097190 hasAuthorship W3146097190A5020298122 @default.
• W3146097190 hasAuthorship W3146097190A5020819058 @default.
• W3146097190 hasAuthorship W3146097190A5023718426 @default.
• W3146097190 hasAuthorship W3146097190A5025578020 @default.
• W3146097190 hasAuthorship W3146097190A5025684845 @default.
• W3146097190 hasAuthorship W3146097190A5026140364 @default.
• W3146097190 hasAuthorship W3146097190A5027475930 @default.
• W3146097190 hasAuthorship W3146097190A5028627935 @default.
• W3146097190 hasAuthorship W3146097190A5030202287 @default.
• W3146097190 hasAuthorship W3146097190A5030921116 @default.
• W3146097190 hasAuthorship W3146097190A5030955342 @default.
• W3146097190 hasAuthorship W3146097190A5031387776 @default.
• W3146097190 hasAuthorship W3146097190A5032764121 @default.
• W3146097190 hasAuthorship W3146097190A5040040696 @default.
• W3146097190 hasAuthorship W3146097190A5040471504 @default.
• W3146097190 hasAuthorship W3146097190A5040908309 @default.
• W3146097190 hasAuthorship W3146097190A5041129699 @default.
• W3146097190 hasAuthorship W3146097190A5043098150 @default.
• W3146097190 hasAuthorship W3146097190A5043360958 @default.
• W3146097190 hasAuthorship W3146097190A5044842689 @default.
• W3146097190 hasAuthorship W3146097190A5045377014 @default.
• W3146097190 hasAuthorship W3146097190A5048295434 @default.
• W3146097190 hasAuthorship W3146097190A5048352086 @default.
• W3146097190 hasAuthorship W3146097190A5048353951 @default.
• W3146097190 hasAuthorship W3146097190A5048826252 @default.
• W3146097190 hasAuthorship W3146097190A5052002691 @default.
• W3146097190 hasAuthorship W3146097190A5053106110 @default.

• next